30 TREATMENTS TO ONE
In 2020, our Ride community will bring the QEII Health Sciences Centre one step closer to introducing a new, world-class procedure – a breast seed brachytherapy program.
Access to a breast seed brachytherapy program will help ensure that some early stage breast cancer patients – from every community across our province – can spend less time at the QEII undergoing radiotherapy. This program will reduce the number of treatments required from 30 to 1. For patients, this means more time at home, focusing on what matters most.
These tiny seeds have a big impact and with our Ride community’s support, we will be able to target breast cancer better than ever before and help ensure our cancer centre has the best treatment options available here at home.
$2.6 MILLION NET RAISED FOR CANCER CARE IN ATLANTIC CANADA
2019
Helped purchase new state-of-the-art diagnostic and treatment equipment for cervical cancer. This new equipment provides an effective and minimally invasive way to diagnose and treat precancerous cell changes before they even develop into cancer.
Funds raised will also help bring Atlantic Canada’s first surgical robotics technology to the QEII – giving patients with a range of cancers shorter hospital stays, less pain, quicker recovery times and, most importantly, a decreased risk of the cancer advancing or recurring.
Our Ride community also funded groundbreaking research to discover new treatments and cures for blood cancer, as well as individualized support programs for cancer patients and their families through The Leukemia & Lymphoma Society of Canada.
2017/2018
Cutting-edge equipment and technology for the new Cancer Therapy Preparation Lab, which will open at the QEII Health Sciences Centre in spring 2020. This state-of-the-art lab will be dedicated to the preparation of all drugs for the treatment and support of cancer patients at the QEII.
With our Ride community helping to fund innovative technologies within the new lab – like bar-coding, remote-cameras, robotics and automation – the QEII’s cancer care team will double the number of therapy doses they can prepare each day, reduce treatment times, and enable new clinical trials.
2016
Endobronchial ultrasound (EBUS) technology, which provides a safer and less-invasive alternative to diagnosing lung cancer and lymphoma. Prior to this purchase, Nova Scotia was the only province in Canada that didn’t have EBUS technology.
2015
An additional apheresis machine – a crucial piece of equipment in blood cancer treatment.
